Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 25/3/20191 min de lectura
Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacterial Disease; Public Workshop; Request for Comments
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacterial Disease." The purpose of the public workshop is to discuss the clinical trial design considerations, including endpoints, related to the development of antibacterial drug products for treatment of nontuberculous mycobacterial (NTM) disease.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →